- Home
- IRT vs TERN Comparison
IRT vs TERN Comparison
Compare IRT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRT | TERN |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IRT | TERN |
|---|---|---|
| Price | $15.85 | $52.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $20.45 | ★ $46.49 |
| AVG Volume (30 Days) | 2.0M | ★ 7.5M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.31% | N/A |
| EPS Growth | ★ 41.18 | 8.04 |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $657,696,000.00 | N/A |
| Revenue This Year | $3.21 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $65.73 | ★ N/A |
| Revenue Growth | ★ 2.76 | N/A |
| 52 Week Low | $14.60 | $2.82 |
| 52 Week High | $19.83 | $53.19 |
Technical Indicators
Market Signals| Indicator | IRT | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 74.74 |
| Support Level | $15.07 | $52.42 |
| Resistance Level | $16.49 | $53.19 |
| Average True Range (ATR) | 0.31 | 0.10 |
| MACD | 0.07 | -0.38 |
| Stochastic Oscillator | 61.98 | 98.78 |
Price Performance
Historical ComparisonAbout IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.